BioLabs

BioLabs was founded with a clear vision: to remove the barriers that prevent life science innovators from bringing their discoveries to market. The company recognized that early-stage biotech startups often struggle to access expensive laboratory space, specialized equipment, and collaborative ecosystems that are essential for scientific breakthroughs. By creating a global network of premium shared laboratories and coworking spaces, BioLabs provides turnkey access to state-of-the-art research facilities, entrepreneurial programming, and deep industry and capital connections.

Today, BioLabs operates as an international, membership-based network of shared lab and office facilities strategically located in key biotech innovation clusters across the United States, Europe, and Asia. The company has grown to span 21 sites across 5 countries and 3 continents, supporting over 500 life science companies that have collectively raised more than $5 billion in funding. These integrated ecosystems enable innovators - from early-stage founders to established R&D teams - to rapidly translate ideas into impact without the constraints of traditional lab ownership. As the physical and community backbone that powers life science discovery worldwide, BioLabs serves as both a catalyst for collaboration and a launchpad for breakthroughs that advance human health and sustainability.